Effects of antihypertensive drug treatments on fracture outcomes: a meta‐analysis of observational studies
Open Access
- 29 August 2006
- journal article
- research article
- Published by Wiley in Journal of Internal Medicine
- Vol. 260 (4), 350-362
- https://doi.org/10.1111/j.1365-2796.2006.01695.x
Abstract
Objective. To quantitatively pool findings from observational studies on the risk of fracture outcomes associated with exposure to five antihypertensive drug classes: angiotensin‐converting enzyme (ACE) inhibitors, diuretics (in particular thiazide diuretics), β‐blockers, calcium‐channel blockers and alpha‐blockers. Design. Systematic review and meta‐analysis. Data sources. Publications listed in the MEDLINE, EMBASE and LILACS databases, the ISI proceedings, and bibliographies of retrieved articles. Sources were searched from the earliest possible dates through December 2005. Review methods. We included case–control and cohort studies presenting relative risks and confidence intervals (CIs) for the association between exposure to antihypertensive agents and fracture outcomes. Data were extracted onto a standardized computer worksheet. Study quality was assessed using a 10‐point questionnaire specific to case–control or cohort study design. Results. Fifty‐four studies were identified. Pooled estimates were computed using the software HEpiMA. The pooled relative risk (RR) of any fracture with use of thiazide diuretics was 0.86 (95% CI 0.81–0.92) and 1.14 (95% CI 0.84–1.54) with use of nonthiazide diuretics. There was a statistically significant reduction of any fracture with use of β‐blockers, (RR 0.86, 95% CI 0.70–0.98). The one study with ACE inhibitor data showed protection (RR 0.81, 95% CI 0.73–0.89). No significant associations were found between fractures and exposure to α‐blockers or calcium‐channel blockers. Conclusions. Thiazide diuretics and β‐blockers appear to lower the risk of fractures in older adults. However, these agents cannot be recommended as preventive therapies for fractures until data from randomized controlled trials have established their efficacy. Patients who use these inexpensive drugs as treatments for hypertension may also benefit from a reduction in fracture risk.Keywords
This publication has 57 references indexed in Scilit:
- β-Blocker Use, BMD, and Fractures in the Study of Osteoporotic FracturesJournal of Bone and Mineral Research, 2005
- Characteristics of lifetime factors, bone metabolism, and bone mineral density in patients with hip fractureJournal of Bone and Mineral Metabolism, 2002
- Adrenergic regulation of bone metabolism: Possible involvement of sympathetic innervation of osteoblastic and osteoclastic cellsMicroscopy Research and Technique, 2002
- Epidemiology and outcomes of osteoporotic fracturesThe Lancet, 2002
- Initiation of nonselective alpha1-antagonist therapy and occurrence of hypotension-related adverse events among men with benign prostatic hyperplasia: a retrospective cohort studyClinical Therapeutics, 2001
- Hypertension in the Very Elderly Trial (HYVET)Drugs & Aging, 2001
- Injuries. Thiazide diuretics and the risk of hip fracture among 70-79 year old women treated for hypertensionEuropean Journal of Public Health, 1997
- Thiazide Diuretic Agents and the Incidence of Hip FractureNew England Journal of Medicine, 1990
- Risk Factors for Falls among Elderly Persons Living in the CommunityNew England Journal of Medicine, 1988
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986